netFormulary
 Report : A-Z HCD items in Formulary 17/06/2021 21:36:16
[Back]
 
Section Status BlueTeq Name
10.01.03 Formulary BlueTeq Abatacept 
08.01.05 Formulary BlueTeq Abemaciclib Verzenios
08.03.04.02 Formulary BlueTeq Abiraterone Zytiga
08.01.05 Formulary BlueTeq Acalabrutinib 
01.05.03 Formulary BlueTeq Adalimumab 
10.01.03 Formulary BlueTeq Adalimumab 
13.05.03 Formulary BlueTeq Adalimumab 
11.08.02 Formulary BlueTeq Aflibercept 
08.01.05 Formulary BlueTeq Alectinib Alecensa
08.02.03 Formulary BlueTeq Alemtuzumab Lemtrada
08.02.03 Formulary BlueTeq Alemtuzumab MabCampath
13.05.01 Formulary BlueTeq Alitretinoin 
10.01.03 Formulary BlueTeq Anakinra 
10.01.03 Formulary BlueTeq Apremilast rheumatology
13.05.03 Formulary BlueTeq Apremilast Dermatology
10.02 Formulary BlueTeq Ataluren 
10.04 Formulary BlueTeq Ataluren 
08.01.05 Formulary BlueTeq Atezolizumab Tecentriq
08.02 Non Formulary BlueTeq Autologous anti-CD19-transduced CD3+ cells Tecartus
09.01.04 Formulary BlueTeq Avatrombopag 
08.01.05 Formulary BlueTeq Avelumab Bavencio
10.01.03 Formulary BlueTeq Baricitinib 
13.05.03 Formulary BlueTeq Baricitinib Olumiant
08.01.01 Formulary BlueTeq Bendamustine 
08.02 Formulary BlueTeq Blinatumomab Blincyto
08.01.05 Formulary BlueTeq Bosutinib Bosulif
08.01.05 Formulary BlueTeq Brentuximab vedotin Adcetris
08.01.05 Formulary BlueTeq Brigatinib Alunbrig
13.05.03 Formulary BlueTeq Brodalumab Dermatology
11.08.02 Formulary BlueTeq Brolucizumab Beovu
08.01.05 Formulary BlueTeq Cabazitaxel Jevtana
08.01.05 Formulary BlueTeq Cabozantinib Cabometyx Cometriq
08.01.05 Formulary BlueTeq Carfilzomib Kyprolis
08.01.05 Formulary BlueTeq Ceritinib Zykadia
10.01.03 Formulary BlueTeq Certolizumab Pegol 
13.05.03 Formulary BlueTeq Certolizumab pegol 
08.01.05 Formulary BlueTeq Cetuximab Erbitux
08.01.03 Formulary BlueTeq Clofarabine 
08.01.05 Formulary BlueTeq Crizotinib Xalkori
08.01.05 Formulary BlueTeq Dacomitinib Vizimpro
08.01.05 Formulary BlueTeq Daratumumab Darzalex
08.03.04.02 Formulary BlueTeq Darolutamide Nubeqa
08.01.05 Formulary BlueTeq Dasatinib Sprycel
06.06.02 Formulary BlueTeq Denosumab Prolia
11.04.01 Formulary BlueTeq Dexamethasone intravitreal implant 
08.01 Formulary BlueTeq Dexrazoxane Cardioxane
08.02.04 Formulary BlueTeq Dimethyl fumarate Tecfidera
13.05.02 Formulary BlueTeq Dimethyl Fumarate  
08.01.02 Formulary BlueTeq Doxorubicin Caelyx ,
Myocet
08.01.05 Formulary BlueTeq Dupilumab 
08.01.05 Formulary BlueTeq Durvalumab Imfinzi
09.01.03 Non Formulary BlueTeq Eculizumab 
09.01.04 Formulary BlueTeq Eltrombopag 
01.04.02 Formulary BlueTeq Eluxadoline 
08.01.05 Formulary BlueTeq Encorafenib Braftovi
08.01.05 Formulary BlueTeq Entrectinib 
04.07.04.02 Formulary BlueTeq Erenumab Aimovig
08.01.05 Formulary BlueTeq Eribulin Halaven
10.01.03 Formulary BlueTeq Etanercept Rheumatology
13.05.03 Formulary BlueTeq Etanercept 
08.01.05 Formulary BlueTeq Everolimus Afinitor
08.01.05 Formulary BlueTeq Everolimus Votubia
10.01.03 Formulary BlueTeq Filgotinib  Jyseleca
08.02.04 Formulary BlueTeq Fingolimod 
11.04.01 Formulary BlueTeq Fluocinolone intravitreal implant 
04.07.04.02 Formulary BlueTeq Fremanezumab Ajovy
04.07.04.02 Formulary BlueTeq Galcanezumab Emgality
08.02.03 Formulary BlueTeq Gemtuzumab Mylotarg
08.01.05 Formulary BlueTeq Gilteritinib 
08.02.04 Formulary BlueTeq Glatiramer Acetate Copaxone
01.05.03 Formulary BlueTeq Golimumab Gastroenterology
10.01.03 Formulary BlueTeq Golimumab 
03.04.02 Formulary BlueTeq Grass pollen extract Grazax
13.05.03 Formulary BlueTeq Guselkumab dermatology
08.01.05 Formulary BlueTeq Ibrutinib Imbruvica
01.05.03 Formulary BlueTeq Infliximab 
10.01.03 Formulary BlueTeq Infliximab 
13.05.03 Formulary BlueTeq Infliximab 
08.02.04 Formulary BlueTeq Interferon Beta Avonex
08.02.04 Formulary BlueTeq Interferon Beta Rebif
08.02.04 Formulary BlueTeq Interferon Beta Betaferon
08.02.04 Formulary BlueTeq Interferon beta Extavia
08.02 Formulary BlueTeq Isatuximab Sarclisa
05.02 Non Formulary BlueTeq Isavuconazole Cresemba
08.01.05 Formulary BlueTeq Ixazomib Ninlaro
13.05.03 Formulary BlueTeq Ixekizumab dermatology
08.01.05 Formulary BlueTeq Larotrectinib Vitrakvi
08.02.04 Formulary BlueTeq Lenalidomide  Revlimid
08.01.05 Formulary BlueTeq Lenvatinib Lenvima
08.01.05 Formulary BlueTeq Lorlatinib 
09.01.04 Formulary BlueTeq Lusutrombopag 
10.02.02 Formulary BlueTeq Mexiletine 167mg Namuscla
08.01.03 Formulary BlueTeq Nelarabine Atriance
08.01.05 Formulary BlueTeq Neratinib Nerlynx
08.01.05 Formulary BlueTeq Nilotinib Tasigna
08.02.04 Formulary BlueTeq Niraparib Zejula
08.02.04 Formulary BlueTeq Nivolumab Opdivo
08.02.03 Formulary BlueTeq Obinutuzumab Gazyvaro
11.08.02 Formulary BlueTeq Ocriplasmin Jetrea
08.02.04 Formulary BlueTeq Olaparib Lynparza
03.04.02 Formulary BlueTeq Omalizumab Xolair
08.02.04 Formulary BlueTeq Osimertinib Tagrisso
08.01.05 Formulary BlueTeq Paclitaxel 
08.03.04.01 Formulary BlueTeq Palbociclib Ibrance
05.03.05 Formulary BlueTeq Palivizumab Synagis
08.01.05 Formulary BlueTeq Panitumumab Vectibix
09.02.01.01 Formulary BlueTeq Patiromer Sorbitex Calcium Veltassa
08.02.04 Formulary BlueTeq Peginterferon Beta-1a Plegridy
08.01.05 Formulary BlueTeq Pembrolizumab Keytruda
08.02.04 Formulary BlueTeq Pembrolizumab Keytruda
08.01.03 Formulary BlueTeq Pemetrexed Alimta
07.04.02 Formulary BlueTeq Pentosan polysulfate Elmiron
08.01.05 Formulary BlueTeq Pertuzumab Perjeta
09.01.07 Non Formulary BlueTeq Plerixafor Mozobil
08.01.05 Formulary BlueTeq Polatuzumab vedotin Polivy
08.02.04 Formulary BlueTeq Pomalidomide Imnovid
08.01.05 Formulary BlueTeq Ponatinib Iclusig
11.08.02 Formulary BlueTeq Ranibizumab 
08.01.05 Formulary BlueTeq Ribociclib Kisqali
13.05.03 Formulary BlueTeq Risankizumab Dermatology
08.02.03 Formulary BlueTeq Rituximab Truxima
08.02.03 Formulary BlueTeq Rituximab MabThera
10.01.03 Formulary BlueTeq Rituximab (rheumatology) 
09.01.04 Formulary BlueTeq Romiplostim 
08.01.05 Formulary BlueTeq Rucaparib Rubraca
08.01.05 Formulary BlueTeq Ruxolitinib Jakavi
10.01.03 Formulary BlueTeq Sarilumab 
13.05.03 Formulary BlueTeq Secukinumab 
08.02.04 Non Formulary BlueTeq Siponimod Mayzent
09.02.01.01 Formulary BlueTeq Sodium Zirconium Cyclosilicate Lokelma
05.03.03.02 Formulary BlueTeq Sofosbuvir Sovaldi
05.03.03.02 Formulary BlueTeq Sofosbuvir and Velpatasvir Epclusa
06.05.01 Formulary BlueTeq Somatropin 
08.01.05 Formulary BlueTeq Sunitinib Sutent
08.01.05 Formulary BlueTeq Talimogene laherparepvec Imlygic
06.06.01 Formulary BlueTeq Teriparatide 
13.05.03 Formulary BlueTeq Tildrakizumab Dermatology
10.01.03 Formulary BlueTeq Tocilizumab 
01.05.03 Formulary BlueTeq Tofacitinib Gastroenterology
10.01.03 Formulary BlueTeq Tofacitinib citrate 
06.05.02 Formulary BlueTeq Tolvaptan Jinarc
08.01.05 Formulary BlueTeq Trametinib Mekinist
08.01.05 Formulary BlueTeq Trastuzumab deruxtecan Enhertu
08.01.05 Formulary BlueTeq Trastuzumab emtansine Kadcyla
08.01.01 Formulary BlueTeq Treosulfan 
08.01.05 Formulary BlueTeq Trifluridine-tipiracil Lonsurf
10.01.03 Formulary BlueTeq Upadacitinib 
01.05.03 Formulary BlueTeq Ustekinumab Gastroenterology
10.01.03 Formulary BlueTeq Ustekinumab rheumatology
13.05.03 Formulary BlueTeq Ustekinumab 
01.05.03 Formulary BlueTeq Vedolizumab 
08.01.05 Formulary BlueTeq Venetoclax Venclyxto
Shropshire and Telford Local Health Economy